ANITA DETCHEMENDY: Open Payments
NPI 1225586936 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 52 payments from 19 companies in 2025. Trend: 2023 $933 · 2024 $689 · 2025 $1,324
Food & beverage: $1,324
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $317 |
| Amgen Inc. | 6 | $183 |
| PFIZER INC. | 12 | $182 |
| Teleflex LLC | 1 | $166 |
| Novo Nordisk Inc | 3 | $55 |
| Lilly USA, LLC | 2 | $45 |
| UCB, Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Abbott Laboratories | 2 | $40 |
| Eisai Inc. | 2 | $35 |
Products named: QULIPTA, BARRIGEL, ZAVZPRET, UBRELVY, NURTEC ODT, MOUNJARO, ELIQUIS, Bimzelx.
Industry payments across MO — which companies pay providers there.
